260 related articles for article (PubMed ID: 29704327)
1. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.
Dao M; Habès D; Taupin JL; Mussini C; Redon MJ; Suberbielle C; Jacquemin E; Gonzales E; Guettier C
Liver Transpl; 2018 Jul; 24(7):897-907. PubMed ID: 29704327
[TBL] [Abstract][Full Text] [Related]
2. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
3. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific anti-HLA antibodies in pediatric renal transplant recipients with creeping creatinine: Prevalence, histological correlations, and impact on patient and graft survival.
Monteverde ML; Chaparro A; Goldberg J; Marcos CY; Padros K; Balbarrey Z; Briones L; Rush D
Pediatr Transplant; 2015 Nov; 19(7):684-90. PubMed ID: 26212912
[TBL] [Abstract][Full Text] [Related]
5. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients.
Cousin VL; Rougemont AL; Rubbia-Brandt L; Wildhaber BE; Villard J; Ferrari-Lacraz S; McLin VA
Transplantation; 2020 Aug; 104(8):1633-1643. PubMed ID: 32732841
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Characteristics of Late Acute Antibody-mediated Rejection in Pediatric Liver Transplantation.
Zhou S; Mitsinikos T; Emamaullee J; Weaver C; Wang L; Shillingford N; Warren M; Bawab JH; Tiwari N; Genyk Y; Thomas D; Parham DM
Transplantation; 2021 Sep; 105(9):2045-2053. PubMed ID: 33031223
[TBL] [Abstract][Full Text] [Related]
8. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
[TBL] [Abstract][Full Text] [Related]
9. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.
Musat AI; Agni RM; Wai PY; Pirsch JD; Lorentzen DF; Powell A; Leverson GE; Bellingham JM; Fernandez LA; Foley DP; Mezrich JD; D'Alessandro AM; Lucey MR
Am J Transplant; 2011 Mar; 11(3):500-10. PubMed ID: 21342448
[TBL] [Abstract][Full Text] [Related]
10. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
[TBL] [Abstract][Full Text] [Related]
11. Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.
Bröcker V; Pfaffenbach A; Habicht A; Chatzikyrkou C; Kreipe HH; Haller H; Scheffner I; Gwinner W; Zilian E; Immenschuh S; Schwarz A; Horn PA; Heinemann FM; Becker JU
Nephrol Dial Transplant; 2013 Dec; 28(12):3101-9. PubMed ID: 24081856
[TBL] [Abstract][Full Text] [Related]
12. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
Haga H; Egawa H; Fujimoto Y; Ueda M; Miyagawa-Hayashino A; Sakurai T; Okuno T; Koyanagi I; Takada Y; Manabe T
Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
[TBL] [Abstract][Full Text] [Related]
13. Significance of C4d staining in ABO-identical/compatible liver transplantation.
Sakashita H; Haga H; Ashihara E; Wen MC; Tsuji H; Miyagawa-Hayashino A; Egawa H; Takada Y; Maekawa T; Uemoto S; Manabe T
Mod Pathol; 2007 Jun; 20(6):676-84. PubMed ID: 17431411
[TBL] [Abstract][Full Text] [Related]
14. Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score's Ability to Determine Long-term Outcome.
O'Leary JG; Smith C; Cai J; Hart B; Jennings LW; Everly M; Klintmalm GB; Demetris AJ
Transplantation; 2017 Sep; 101(9):2062-2070. PubMed ID: 28452922
[TBL] [Abstract][Full Text] [Related]
15. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments.
Kelly D; Verkade HJ; Rajanayagam J; McKiernan P; Mazariegos G; Hübscher S
Liver Transpl; 2016 Nov; 22(11):1593-1602. PubMed ID: 27543906
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated rejection in the liver allograft.
Hübscher SG
Curr Opin Organ Transplant; 2012 Jun; 17(3):280-6. PubMed ID: 22569512
[TBL] [Abstract][Full Text] [Related]
17. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
[TBL] [Abstract][Full Text] [Related]
18. Obliterative portal venopathy: A histopathologic finding associated with chronic antibody-mediated rejection in pediatric liver allografts.
Guerra MR; Naini BV; Scapa JV; Reed EF; Busuttil RW; Cheng EY; Farmer DG; Vargas JH; Venick RS; McDiarmid SV; Wozniak LJ
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29363222
[TBL] [Abstract][Full Text] [Related]
19. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.
Martelius T; Halme L; Arola J; Höckerstedt K; Lautenschlager I
Transpl Immunol; 2009 Sep; 21(4):244-6. PubMed ID: 19540918
[TBL] [Abstract][Full Text] [Related]
20. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
